Department of Radiology, Albert Einstein College of Medicine and Montefiore Medical Center, 111 E 210th Street, Bronx, New York, NY, 10467, USA.
Graduate Medical Education, Virginia Mason Medical Center, 925 Seneca Street, Seattle, WA, 98101, USA.
Eur Radiol. 2019 Nov;29(11):6245-6255. doi: 10.1007/s00330-019-06202-y. Epub 2019 Apr 16.
To determine all-cause mortality risk in patients with and without adrenal incidentaloma.
Retrospective cohort study of patients with CT abdomen performed within 24 h of emergency room presentation at an academic medical center from January 1, 2005, to December 31, 2009, without history of adrenal disease, adrenal lab testing, or cancer. Incidentaloma cohort identified by database query of imaging reports followed by manual review and matched to no-nodule controls at 3:1 on age ± 1 year and exam date ± 3 months. Mortality ascertained by in-hospital deaths and National Death Index query. Survival analysis performed with Kaplan-Meier curves and Cox proportional hazards models.
Among 42,575 adults with abdominal CT exams, 969 adrenal incidentaloma patients and 2907 no-nodule controls were identified. All 3876 individuals entered survival analysis with 31,182 person-years at risk (median follow-up 8.9 years [IQR, 6.9-10.7]). All-cause mortality was significantly higher among those with adrenal incidentalomas (353/969, 36.4%) compared with those without (919/2907, 31.6%; mortality difference 7.6 per 1000 person-years; multivariable-adjusted hazard ratio [aHR] 1.14; 95% CI, 1.003-1.29). Exploratory analyses, limited by missing covariates, found that adrenal incidentalomas were associated with significantly increased incidence of malignancy (aHR 1.61; 95% CI, 1.22-2.12), diabetes (aHR 1.43; 95% CI, 1.18-1.71), heart failure (aHR 1.32; 95% CI, 1.07-1.63), peripheral vascular disease (aHR 1.28; 95% CI, 1.95-1.56), renal disease (aHR 1.21; 95% CI, 1.01-1.44), and chronic pulmonary disease (aHR 1.22; 95% CI, 1.01-1.46) compared with controls.
Adrenal incidentalomas are associated with increased mortality and may represent a clinically valuable biomarker.
• Adrenal incidentalomas are associated with increased mortality. • Adrenal incidentaloma size is not predictive of mortality. • On exploratory analyses, adrenal incidentalomas are associated with chronic illnesses.
确定有和无肾上腺意外瘤患者的全因死亡率风险。
这是一项回顾性队列研究,纳入了 2005 年 1 月 1 日至 2009 年 12 月 31 日期间在学术医疗中心就诊的患者,这些患者在急诊科就诊时在 24 小时内进行了腹部 CT 检查,且无肾上腺疾病病史、肾上腺实验室检查或癌症病史。通过数据库查询影像学报告确定意外瘤患者队列,然后进行人工审查,并按年龄相差 1 岁和检查日期相差 3 个月的 3:1 比例与无结节对照进行匹配。通过院内死亡和国家死亡指数查询确定死亡率。采用 Kaplan-Meier 曲线和 Cox 比例风险模型进行生存分析。
在 42575 例进行腹部 CT 检查的成年人中,确定了 969 例肾上腺意外瘤患者和 2907 例无结节对照。所有 3876 名个体进入生存分析,风险人数为 31182 人年(中位随访 8.9 年[IQR,6.9-10.7])。与无意外瘤患者相比,有意外瘤患者的全因死亡率明显更高(353/969,36.4%比 919/2907,31.6%;死亡率差异为每 1000 人年 7.6 例;多变量调整后的风险比[aHR]为 1.14;95%CI,1.003-1.29)。由于缺少协变量,探索性分析发现,与对照组相比,意外瘤与恶性肿瘤(aHR 1.61;95%CI,1.22-2.12)、糖尿病(aHR 1.43;95%CI,1.18-1.71)、心力衰竭(aHR 1.32;95%CI,1.07-1.63)、外周血管疾病(aHR 1.28;95%CI,1.95-1.56)、肾脏疾病(aHR 1.21;95%CI,1.01-1.44)和慢性肺部疾病(aHR 1.22;95%CI,1.01-1.46)的发生率显著增加有关。
肾上腺意外瘤与死亡率升高有关,可能代表一种有临床价值的生物标志物。
•肾上腺意外瘤与死亡率升高相关。•意外瘤大小与死亡率无相关性。•通过探索性分析,意外瘤与慢性疾病相关。